Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/22/2021
Teva debuts generic Perforomist
Teva’s generic Perforomist is indicated to treat bronchoconstriction in patients with chronic obstructive pulmonary disease. - 6/22/2021
Hy-Vee attempts to set Guinness World Records title
Hy-Vee will attempt to break the Guinness World Records title for the largest serving of pancakes, which will be donated to Harvesters - The Community Food Network in Kansas City. - 6/22/2021
NACDS, community leaders look to increase COVID vaccination rates
The National Association of Chain Drug Stores is working with various organizations to help get 70% of adults in the United States vaccinated with at least one dose of a COVID-19 vaccine by July 4. - 6/22/2021
Afterpay expands service to retailers
Consumers can use Afterpay to pay over time without having to pay interest or finance charges. - 6/21/2021
IQVIA’s Long sizes up trends impacting pharmaceutical market in DSN webinar
IQVIA's Doug Long provided data on the first half of the year and how retail pharmacy and the U.S. pharmaceutical market have performed, as well as an update on COVID-19 vaccinations. - 6/21/2021
NACDS praises Texas law for ensuring access to pharmacy-based care
The new law prioritizes patient health and patient access, protecting Texans’ ability to receive pharmacy services from their chosen pharmacy provider. - 6/21/2021
Dr. Reddy’s intros icosapent ethyl
Icosapent ethyl is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia, the company said. - 6/21/2021
Amici Pharma debuts generic Zaroxolyn
Amici’s generic Zaroxolyn is available in dosage strengths of 2.5 mg, 5 mg and 10 mg. - 6/21/2021
Breckenridge, Aggrega Pharma sign multiproduct agreement
The agreement currently covers eight products in a variety of dosage forms, including solid oral, nasal spray, ophthalmic, injectable and transdermal. - 6/21/2021
Sun Pharma reaches patent litigation settlement for generic Revlimid
Sun Pharma will be able to manufacture and sell a limited quantity of generic lenalidomide capsules after March 2022, as well as an unlimited quantity beginning Jan. 31, 2026.
